Bumetanide 1 MG Oral Tablet
INDICATIONS AND USAGE Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. Successful treatment with bumetanide tablets following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.
heritage pharma labs, inc
ROUND YELLOW 701
Related Pills
Bumetanide 1 MG Oral Tablet
heritage pharma labs, inc
ertugliflozin 5 MG Oral Tablet Steglatro
Merck Sharp & Dohme Corp.
levocetirizine dihydrochloride 5 MG Oral Tablet
Teva Pharmaceuticals USA, Inc.
metoprolol 100 mg
twi pharmaceuticals, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
BUMEtanIDE Tablets USP are available as green, round, flat-faced, beveled edge, plain on one side and debossed with "700" on other side, containing 0.5 mg
BUMEtanIDE, USP packaged in bottles of 100 tablets (NDC 14539-700-01), 500 tablets (NDC 14539-700-05), and 1000 tablets (NDC 14539-700-10).
BUMEtanIDE Tablets USP are available as yellow, round, flat-faced, beveled edge, plain on one side and debossed with"701" on other side, containing 1 mg
BUMEtanIDE, USP packaged in bottles of 100 tablets (NDC 14539-701-01), 500 tablets (NDC 14539-701-05) and 1000 tablets (NDC 14539-701-10).
BUMEtanIDE Tablets USP are available as peach, round, flat-faced, beveled edge, plain on one side and debossed with "702" on other side, containing 2 mg
BUMEtanIDE, USP packaged in bottles of 100 tablets (NDC 14539-702-01), 500 tablets (NDC 14539-702-05) and 1000 tablets (NDC 14539-702-10). Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Manufactured by: Centaur Pharmaceuticals Pvt. Ltd. Hinjewadi, Pune-411057, India. Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816 1.866.901.DRUG (3784) Revised: 11/2019 OR Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816 1.866.901.DRUG (3784) 51U000000362US01 Revised: 05/2020 Image logo
More pills like ROUND 701